CNCR vs. SURI

Last updated Jun 3, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and SURI (Simplify Propel Opportunities ETF) are both Health & Biotech Equities funds. CNCR is passively managed, while SURI is actively managed. CNCR charges 0.79%/yr vs 2.51%/yr for SURI.

Performance

CNCR vs. SURI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Simplify Propel Opportunities ETF (SURI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

SURI

• 1D: -1.45%
• 1M: 0.71%
• YTD: 7.33%
• 6M: 5.21%
• 1Y: 37.33%
• 3Y*: 7.35%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. SURI - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
SURI Simplify Propel Opportunities ETF	11.16%

CNCR vs. SURI - Sectors Allocation Comparison

Sectors	CNCR	SURI
Healthcare	96.6%	56.4%
Financial Services	3.3%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	43.6%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CNCR vs. SURI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SURI

SURI Risk / Return Rank: 51
SURI Sharpe Ratio Rank: 46
SURI Sortino Ratio Rank: 47
SURI Omega Ratio Rank: 44
SURI Calmar Ratio Rank: 66
SURI Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. SURI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Simplify Propel Opportunities ETF (SURI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CNCR	SURI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.65	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.16	—

Drawdowns

CNCR vs. SURI - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum SURI drawdown of -47.76%. Use the drawdown chart below to compare losses from any high point for CNCR and SURI.

Drawdown Indicators

	CNCR	SURI	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-47.76%	+47.76%
Max Drawdown (1Y) Largest decline over 1 year	—	-11.78%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-47.76%	—
Current Drawdown Current decline from peak	0.00%	-16.51%	+16.51%
Average Drawdown Average peak-to-trough decline	0.00%	-17.37%	+17.37%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	4.13%	—

Volatility

Volatility by Period

	CNCR	SURI	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.32%	—
Volatility (6M) Calculated over the trailing 6-month period	—	14.26%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	22.78%	-22.78%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	28.28%	-28.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	28.28%	-28.28%

CNCR vs. SURI - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is lower than SURI's 2.51% expense ratio.

Dividends

CNCR vs. SURI - Dividend Comparison

CNCR has not paid dividends to shareholders, while SURI's dividend yield for the trailing twelve months is around 15.86%.

Position	TTM	2025	2024	2023
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%
SURI Simplify Propel Opportunities ETF	15.86%	16.31%	21.41%	14.71%

Frequently Asked Questions

Which ETF is better, CNCR or SURI?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or SURI?

CNCR is cheaper with a 0.79% expense ratio, compared with 2.51% for SURI.

Which ETF pays a higher dividend yield, CNCR or SURI?

SURI has the higher dividend yield at 15.86%, compared with 0.00% for CNCR.

What is the main difference between CNCR and SURI?

They also come from different issuers: Exchange Traded Concepts and Simplify. Their fees differ too: 0.79% for CNCR and 2.51% for SURI.